Identification | Back Directory | [Name]
Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxotetradecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphapentacos-1-yl]-ω-methoxy- | [CAS]
261764-82-3 | [Synonyms]
Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxotetradecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphapentacos-1-yl]-ω-methoxy- | [Molecular Formula]
(C2H4O)nC35H68NO10P | [MOL File]
261764-82-3.mol |
Hazard Information | Back Directory | [Description]
DMPE-mPEG(2000) is a PEGylated derivative of 1,2-dimyristoyl-sn-glycero-3-PE (DMPE). It has been used in the synthesis of nanostructured lipid carriers (NLCs) for use in ocular administration of ciprofloxacin (Item No. 14286).1WARNING This product is not for human or veterinary use. | [References]
[1] SAI PRACHETAN BALGURI . Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol[J]. International Journal of Pharmaceutics, 2017, 529 1: Pages 32-43. DOI: 10.1016/j.ijpharm.2017.06.042 |
|
|